Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial

BMC Cancer

Nicolas Briez³  Guillaume Piessen³  Franck Bonnetain¹²  Cécile Brigand⁹  Nicolas Carrere¹¹  Denis Collet⁷  Christophe Doddoli⁸  Renaud Flamein²  Jean-Yves Mabrut¹³  Bernard Meunier¹  Simon Msika⁵  Thierry Perniceni⁶  Frédérique Peschaud⁴  Michel Prudhomme¹⁰  Jean-Pierre Triboulet³  Christophe Mariette³ 

[1] Department of Digestive Surgery, Pontchaillou University Hospital, Rue Henri Le Guilloux, Rennes, F-35033, France

[2] Department of Digestive Surgery, University Hospital, Boulevard Montalembert, Clermont-Ferrand, F-63003, France

[3] Faculty of Medicine Henri Warembourg, University of Lille 2, Lille, F-59045, France

[4] Department of Digestive Surgery, Ambroise Paré University Hospital, Boulevard Charles de Gaulle, Boulogne Billancourt, F-92104, France

[5] Department of Digestive Surgery, Louis Mourrier University Hospital, Rue des Renouillers, Colombes, F-92701, France

[6] Department of Digestive Surgery, Institut Mutualiste Montsouris, Boulevard Jourdan, Paris, F-75014, France

[7] Department of Digestive Surgery, Pessac University Hospital, Avenue de Magellan Bordeaux, F-33604, France

[8] Department of Digestive Surgery, Nord University Hospital, Chemin des Bourrely, Marseille, F-13915, France

[9] Department of Digestive Surgery, University Hospital, Avenue Molière, Strasbourg, F-67200, France

[10] Department of Digestive Surgery, University Hospital, Place du Pr Robert Debré, Nîmes, F-30029, France

[11] Department of Digestive Surgery, Purpan University Hospital, Place du Dr Baylac, Toulouse, F-31059, France

[12] Biostatistic and Epidemiological Unit, EA 4184, Centre Georges François Leclerc, 1 rue du Pr Marion, Dijon, F-21079, France

[13] Department of Digestive Surgery, Croix-Rousse University Hospital, Grande Rue de la Croix Rousse, Lyon, F-69004, France

关键词: randomised controlled trial;    oesophagectomy;    minimally invasive surgery;    surgery;    oesophageal cancer;   

Others  :  1080825
DOI  :  10.1186/1471-2407-11-310

 received in 2011-06-14, accepted in 2011-07-23,  发布年份 2011

【 摘 要 】

Background

Open transthoracic oesophagectomy is the standard treatment for infracarinal resectable oesophageal carcinomas, although it is associated with high mortality and morbidity rates of 2 to 10% and 30 to 50%, respectively, for both the abdominal and thoracic approaches. The worldwide popularity of laparoscopic techniques is based on promising results, including lower postoperative morbidity rates, which are related to the reduced postoperative trauma. We hypothesise that the laparoscopic abdominal approach (laparoscopic gastric mobilisation) in oesophageal cancer surgery will decrease the major postoperative complication rate due to the reduced surgical trauma.

Methods/Design

The MIRO trial is an open, controlled, prospective, randomised multicentre phase III trial. Patients in study arm A will receive laparoscopic-assisted oesophagectomy, i.e., a transthoracic oesophagectomy with two-field lymphadenectomy and laparoscopic gastric mobilisation. Patients in study arm B will receive the same procedure, but with the conventional open abdominal approach. The primary objective of the study is to evaluate the major postoperative 30-day morbidity. Secondary objectives are to assess the overall 30-day morbidity, 30-day mortality, 30-day pulmonary morbidity, disease-free survival, overall survival as well as quality of life and to perform medico-economic analysis. A total of 200 patients will be enrolled, and two safety analyses will be performed using 25 and 50 patients included in arm A.

Discussion

Postoperative morbidity remains high after oesophageal cancer surgery, especially due to major pulmonary complications, which are responsible for 50% of the postoperative deaths. This study represents the first randomised controlled phase III trial to evaluate the benefits of the minimally invasive approach with respect to the postoperative course and oncological outcomes in oesophageal cancer surgery.

Trial Registration

NCT00937456 (ClinicalTrials.gov)

【 授权许可】

   
2011 Briez et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Mariette C, Piessen G, Triboulet JP: Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007, 8:545-53.
• [2]Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, ten Kate FJ, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJ: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002, 347:1662-9.
• [3]Gemmill EH, McCulloch P: Systematic review of minimally invasive resection for gastro-esophageal cancer. Br J Surg 2007, 94:1461-7.
• [4]Decker G, Coosemans W, De Leyn P, Decaluwé H, Nafteux P, Van Raemdonck D, Lerut T: Minimally invasive esophagectomy for cancer. Eur J Cardiothorac Surg 2009, 35:13-20.
• [5]Berger AC, Bloomenthal A, Weksler B, Evans N, Chojnacki KA, Yeo CJ, Rosato EL: Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomy. J Am Coll Surg 2011, 212:560-6.
• [6]Bresadola V, Terrosu G, Cojutti A, Benzoni E, Baracchini E, Bresadola F: Laparoscopic versus open gastroplasty in esophagectomy for esophageal cancer: a comparative study. Surg Laparosc Endosc Percutan Tech 2006, 16:63-7.
• [7]Bernabe KQ, Bolton JS, Richardson WS: Laparoscopic hand-assisted versus open transhiatal esophagectomy: a case-control study. Surg Endosc 2005, 19:334-7.
• [8]Nguyen NT, Follette DM, Wolfe BM, Schneider PD, Roberts P, Goodnight JE Jr: Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy. Arch Surg 2000, 135:920-5.
• [9]Smithers BM, Gotley DC, Martin I, Thomas JM: Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg 2007, 245:232-40.
• [10]Biere SS, Maas KW, Bonavina L, Garcia JR, van Berge Henegouwen MI, Rosman C, Sosef MN, de Lange ES, Bonjer HJ, Cuesta MA, van der Peet DL: Traditional invasive vs. minimally invasive esophagectomy: a multi-center, randomized trial (TIME-trial). BMC Surg 2011, 11:2. BioMed Central Full Text
• [11]D'journo XB, Michelet P, Avaro JP, Trousse D, Giudicelli R, Fuentes P, Doddoli C, Thomas P: Respiratory complications after oesophagectomy for cancer. Rev Mal Respir 2008, 25:683-94.
• [12]Jagot P, Sauvanet A, Berthoux L, Belghiti J: Laparoscopic mobilization of the stomach for oesophageal replacement. Br J Surg 1996, 83:540-2.
• [13]Bonavina L, Bona D, Binyom PR, Peracchia A: A laparoscopy-assisted surgical approach to esophageal carcinoma. J Surg Res 2004, 117:52-7.
• [14]Godiris-Petit G, Munoz-Bongrand N, Honigman I, Cattan P, Sarfati E: Minimally invasive esophagectomy for cancer: prospective evaluation of laparoscopic gastric mobilization. World J Surg 2006, 30:1434-40.
• [15]Cense HA, Busch OR, Bemelman WA, Obertop H, van Lanschot JJ: Results of the ecombination of open transthoracic esophagectomy with laparoscopic gastric tube formation for esophageal cancer. Dig Surg 2006, 23:164-8.
• [16]Holscher AH, Schneider PM, Gutschow C, Schroder W: Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Ann Surg 2007, 245:241-6.
• [17]Clavien PA, Sanabria JR, Strasberg SM: Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 1992, 111:518-26.
• [18]Sobin LH, Gospodarowicz MK, Wittekind C: International Union Against Cancer (UICC) TNM classification of malignant tumours. 7th edition. New York: Wiley-Liss; 2010.
• [19]Bonnetain F, Dahan L, Maillard E, Ychou M, Mitry E, Hammel P, Legoux JL, Rougier P, Bedenne L, Seitz JF: Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma. Eur J Cancer 2010, 46:2753-62.